PMV Pharmaceuticals, Inc.
USD1.32
+0.04 (+2.71%)
CEO
David H. Mack
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.31
Prev. Close
$1.29
Day Low
$1.29
Day High
$1.33
52W Low
$0.96
52W High
$1.88
Market Cap
$0.07B
Volume
0.04M
| -1.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -30.6% | -27.3% | 0.06 | 14.78 | -2.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -29.8% | -27.1% | 0.06 | 22.80 | -5.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -18.7% | -17.4% | 0.04 | 24.66 | -18.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -9.6% | -9.4% | 0.00 | 56.90 | -80.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 36.0% | -24.6% | 0.00 | 22.57 | -63.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 38.0% | -27.6% | -2.32 | 26.75 | -6.5 |
| -0.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -17.4% | -15.7% | 0.01 | 10.76 | -0.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -15.1% | -13.9% | 0.01 | 12.52 | -0.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -10.9% | -10.2% | 0.01 | 16.75 | -0.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -13.1% | -12.0% | 0.01 | 12.22 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -9.7% | -8.6% | 0.07 | 13.98 | -1.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -0.6% | -0.5% | 0.06 | 19.22 | -16.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -7.2% | -6.4% | 0.06 | 16.79 | -1.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -7.0% | -6.2% | 0.06 | 14.78 | -2.5 |